10/11/2024Japan Strengthens Pharmaceutical Supply Chain to Reduce Dependence on ...

10/11/2024CanSino Receives Over $17M from Gates Foundation to Accelerate Polio V...

10/11/2024Chinese Health Insurance Premium Income Up 4.5% in 2023

10/11/2024Recent Executive Moves

10/10/2024QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...

10/10/2024Nona Biosciences Enters Strategic Collaboration with OverT Bio to Adva...

10/10/2024InnoCare Announces Phase II Study Results of TYK2 Inhibitor ICP-488 Me...

10/10/2024Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab

10/10/2024CDE Solicits Comments on the Proposed Announcement on Rewarding Intern...

10/10/2024CDE Issues the Technical Guidelines for the Analysis and Handling of S...

10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...

10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...

10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...

10/10/2024Bio-Thera Secures $110M Drug Licensing Deal with Hungary's Gedeon Rich...

10/9/2024NMPA Announces Package Insert Revision of Mezlocillin Sodium Containin...

10/9/2024Bayer Launches Life Sciences Incubator in Shanghai

10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms

10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023

10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...

10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...

10/8/2024AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...

10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 

10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...

10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor

10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...

10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...

10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...

10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...

10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...

10/8/2024CDE Issues the List of Reference Formulations for GQCE Studies (83rd B...

Page:46/774 Total number of articles:23207: [First][<<] [44] [45] [46] [47] [48] [>>] [End]